Athens Medical C.S.A. (ATH:IATR)

Athens Medical C.S.A. Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	31.3	17.51	21.96	16.68	51.99
Trading Asset Securities	0.25	-	-	-	-
Cash & Short-Term Investments	31.55	17.51	21.96	16.68	51.99
Cash Growth	80.18%	-20.27%	31.65%	-67.91%	5.54%
Accounts Receivable	156.72	142.02	149.65	117.44	83.05
Other Receivables	7.56	8.03	8.26	10.32	11.01
Receivables	164.27	150.06	157.91	127.75	94.07
Inventory	7.83	7.21	6.94	7	7
Prepaid Expenses	9.05	9.21	1.8	0.85	0.84
Other Current Assets	6.91	7.89	8.38	7.52	9.55
Total Current Assets	219.61	191.87	197	159.81	163.45
Property, Plant & Equipment	299.32	292.12	272.46	254.66	249.69
Long-Term Investments	2.52	1.81	1.31	-	-
Other Intangible Assets	7.43	6.21	2.76	1.33	1
Long-Term Deferred Tax Assets	0.07	0.05	0.03	0.06	0.07
Other Long-Term Assets	3.84	3.8	3.79	2.23	2.19
Total Assets	532.78	495.86	477.34	418.09	416.39

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	120.53	104.17	90.65	80.14	63.28
Accrued Expenses	20.22	21.36	21.01	16.24	22.94
Short-Term Debt	86.8	36.15	30.25	0.19	-
Current Portion of Long-Term Debt	13.22	20.49	20.37	17.59	16.71
Current Portion of Leases	6.44	6.2	6.03	4.86	4.54
Current Income Taxes Payable	26.69	26.6	19.44	15.03	16.58
Other Current Liabilities	13.65	15.8	12.54	11.44	11.27
Total Current Liabilities	287.55	230.76	200.29	145.5	135.32
Long-Term Debt	60.46	69.76	89.74	110.58	116.73
Long-Term Leases	15.49	14.72	12.11	10.83	12.66
Pension & Post-Retirement Benefits	8.37	7.84	7	6.22	6.49
Long-Term Deferred Tax Liabilities	20.28	20.07	19.5	18.58	16.12
Other Long-Term Liabilities	36.58	43.9	39.93	23.12	27.07
Total Liabilities	428.72	387.05	368.57	314.82	314.38

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	26.89	26.89	26.89	26.89	26.89
Additional Paid-In Capital	11.1	11.1	11.1	13.71	19.78
Retained Earnings	65.97	70.68	70.74	62.73	55.46
Comprehensive Income & Other	-0.06	-0.07	-0.07	-0.07	-0.07
Total Common Equity	103.9	108.61	108.67	103.25	102.06
Minority Interest	0.16	0.21	0.1	0.02	-0.05
Shareholders' Equity	104.06	108.81	108.77	103.28	102.02
Total Liabilities & Equity	532.78	495.86	477.34	418.09	416.39

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	182.41	147.31	158.51	144.06	150.64
Net Cash (Debt)	-150.86	-129.8	-136.55	-127.37	-98.65
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.74	-1.50	-1.57	-1.47	-1.14
Filing Date Shares Outstanding	86.74	86.74	86.74	86.74	86.74
Total Common Shares Outstanding	86.74	86.74	86.74	86.74	86.74
Working Capital	-67.94	-38.89	-3.3	14.31	28.13
Book Value Per Share	1.20	1.25	1.25	1.19	1.18
Tangible Book Value	96.47	102.4	105.91	101.92	101.07
Tangible Book Value Per Share	1.11	1.18	1.22	1.18	1.17
Land	63.58	59.77	59.73	59.18	55.59
Buildings	271.95	264.23	237.29	232.25	212.94
Machinery	186.71	178.1	165.16	154.01	138.98
Construction In Progress	10.77	7.27	21.57	11.87	7.93

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error